Correlation between HbA1c and lipid profile in diabetes: a primary health concern in Aseer, Saudi Arabia
DOI:
https://doi.org/10.26555/eshr.v5i2.6129Keywords:
Correlation, HbA1c, lipid profile, Type 2 diabetes mellitus, Saudi ArabiaAbstract
Background: Type 2 diabetes mellitus (T2DM) presently affects 537 million adults globally. It has a high prevalence in the Saudi population (31.6%), ranking 2nd highest in the Middle East and 7th worldwide. T2DM is characterized by insulin resistance and hyperglycemia, causing the glycation of hemoglobin, plasma proteins, tissue proteins, and their receptors. The high insulinemic state leads to dyslipidemia. These biochemical alterations can cause complications like atherosclerosis, coronary artery disease, angina, myocardial infarctions, and hypertension. Considering the high prevalence of diabetes in the Saudi population and the lack of studies conducted at primary health care (PHC) centers in Saudi Arabia, this study was done to investigate the status of diabetes control in T2DM patients and propose appropriate measures to prevent the development of future complications.
Method: This cross-sectional study recruited 191 known T2DM patients presenting at the PHC center in the Al Qabil locality of Aseer province of Saudi Arabia. The patient's demographic and glycemic and lipid profile data were recorded and statistically analyzed.
Results: T2DM was more prevalent in males. T2DM patients were found to be obese, and 52% had coexisting hypertension. Patients had deranged glycemic profiles and dyslipidemia despite taking hypoglycemic agents. Hyperglycemia and dyslipidemia were significantly higher in people with diabetes having HbA1c > 7. HbA1c is correlated with dyslipidemia, and dyslipidemia is linked considerably with obesity.
Conclusion: T2DM patients must be regularly followed up to ensure drug compliance, explained about foreseen medical complications, and motivated to adopt lifestyle modification measures to control their weight, BP, and blood glucose.
References
International Diabetes Federation. IDF Diabetes Atlas, 10th Edition. 2021.
Meo SA, Usmani AM, Qalbani E. Prevalence of type 2 diabetes in the Arab world: impact of GDP and energy consumption. Eur Rev Med Pharmacol Sci. 2017;21(6):1303–12.
Al Dawish M, Robert A, Braham R, Al Hayek A, Al Saeed A, Ahmed R, et al. Diabetes Mellitus in Saudi Arabia: A Review of the Recent Literature. Curr Diabetes Rev. 2016;12(4):359–68.
Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K. Microvascular complications of Type 2 Diabetes mellitus. Curr Vasc Pharmacol. 2020;18(2):117–24.
Wang Y, Beydoun M. Meat consumption is associated with obesity and central obesity among US adults. Int J Obes. 2009;33(6):621–8.
Bays HE, Toth PP, Kris-Etherton PM, Abate N, Aronne LJ, Brown WV, et al. Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association. J Clin Lipidol. 2013;7(4):304–83.
Cercato C, Fonseca FA. Cardiovascular risk and obesity. Diabetol Metab Syndr. 2019;11(1):1–15.
Fuchs FD, Whelton PK. High Blood Pressure and Cardiovascular Disease. Hypertension. 2020;(Cvd):285–92.
Pedersen T, Kjekshus J, Berg K, Haghfelt T, Faergeman O, Faergeman G, et al. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). J Atheroscler. 1994;5(3):81–7.
Wong ND. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol. 2014;11(5):276–89.
Berliner J, Navab M, Fogelman A, Frank J, Demer L, Edwards P, et al. Atherosclerosis: basic mechanisms oxidation, inflammation, and genetics. Circulation. 1995;91(9):2488–96.
Gordon T, Castelli W, Hjortland M, Kannel W, Dawber T. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977;62(5):707–14.
Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement fromthe European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459–72.
Yaghi S, Elkind MSV. Lipids and Cerebrovascular Disease: Research and Practice. Stroke. 2015;46(11):3322–8.
Tasneem A, Vemuri H, Shaik M, Khan M. Correlation between Glycosylated Haemoglobin and Dyslipidaemia in Patients with Type 2 Diabetes Mellitus. Int J Health Sci (Qassim). 2021;4(24):1–3.
Anderson KM. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA J Am Med Assoc. 1987;257(16):2176–80.
Nickenig G. Central role of the AT(1)-receptor in atherosclerosis. J Hum Hypertens. 2002;16:26–33.
Nickenig G, Harrison D. Current Perspective The AT1 -Type Angiotensin Receptor in Oxidative Stress and Atherogenesis Part II: AT1 Receptor Regulation. Circulation. 2002;530–6.
Nickenig G, Harrison D. Current Perspective Current Perspective The AT1 -Type Angiotensin Receptor in Oxidative Stress and Atherogenesis Part I: Oxidative Stress and Atherogenesis. Circulation. 2002;393–6.
Khavandi M, Duarte F, Ginsberg HN, Reyes-Soffer G. Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes. Curr Cardiol Rep. 2017;19(1):1–16.
Dolzhenko M, Barnett O, Grassos C, Dragomiretska N, Goloborodko B, Ilashchuk T, et al. Management of Dyslipidemia in Individuals with Low-to-Moderate Cardiovascular Risk: Role of Nutraceuticals. Adv Ther. 2020;37(11):4549–67.
Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M. Complications of Diabetes 2017 Konstantinos. J Diabetes Res. 2018;2018, Arti:4.
Khaltaev N, Axelrod S. Global trends in diabetes-related mortality with regard to lifestyle modifications, risk factors, and affordable management: A preliminary analysis. Chronic Dis Transl Med. 2021;7(3):182–9.
Bird S, Hawley J. Update on the effects of physical activity on insulin sensitivity in humans. BMJ Open Sport Exerc Med. 2017;2(1):1–26.
Mellergård E, Johnsson P, Eek F. Developing a web-based support using self-affirmation to motivate lifestyle changes in type 2 diabetes: A qualitative study assessing patient perspectives on self-management and views on a digital lifestyle intervention. Internet Interv. 2021;24(March):100384.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Fatima Riaz, Archana Nimesh
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with ESHR agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
